NCT02779699View on ClinicalTrials.gov

A Study of AL2846 on Tolerance and Pharmacokinetics

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Advanced Cancer
Interventions
DRUG

AL2846

AL2846 p.o. qd

Trial Locations (1)

100021

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY